An official website of the United States government

Search
Filters

Study Acronym

DPP

1 - 39 of 39 Results
  • Previous
  • 1(current)
  • Next
Page
Show:
Study Search Results Table
Title
PMID
PMCID
Public Release Type
Publication Year
DOI
Study Acronym
Request ID(s)
Public Release Origin
A long-term mechanistic computational model of physiological factors driving the onset of type 2 diabetes in an individual.29444133PMC5812629Journal201810.1371/journal.pone.0192472DPPOS, DPP20879Secondary Research
Assessing Heterogeneity in Surrogacy Using Censored DataJournal2024DPPOS, DPP23555Secondary Research
Association of Perfluoroalkyl and Polyfluoroalkyl Substances With AdiposityJournal201810.1001/jamanetworkopen.2018.1493DPP, DPPOS20499Secondary Research
Baseline participant characteristics and risk for dropout from ten obesity randomized controlled trials: a pooled analysis of individual level data.25599077PMC4296899Journal201410.3389/fnut.2014.00025DPP87Secondary Research
Can Earlier Biomarker Measurements Explain a Treatment Effect on Diabetes Incidence? A Robust Comparison of Four Surrogate MarkersJournal2023DPP, DPPOS23555Secondary Research
Common Variants in the 7 Amp Kinase Genes and Progression to Diabetes in the Diabetes Prevention Program (dpp).Journal2007DPPContributing Study
Comparison among criteria to define successful weight-loss maintainers and regainers in the Action for Health in Diabetes (Look AHEAD) and Diabetes Prevention Program trials.29046304PMC5698838Journal201710.3945/ajcn.117.157446DPPOS, DPP20943, 21251Secondary Research
Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.28803840PMC5769867Journal201710.1016/S2213-8587(17)30221-8DPP, DPPOS21387Secondary Research
Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors35339377Journal202210.1016/j.jdiacomp.2022.108180DPP, DPPOS, DCCT/EDIC, CRIC21415Secondary Research
Evaluating Community-Based Translational Interventions Using Historical Controls: Propensity Score vs. Disease Risk Score ApproachConference Presentation2015DPP4048Secondary Research
Evaluating Community-Based Translational Interventions Using Historical Controls: Propensity Score vs. Disease Risk Score Approach.30747394PMC6520136Journal201910.1007/s11121-019-0980-3DPP4048Secondary Research
Evaluating surrogate marker information using censored data.28088843PMC5413393Journal201710.1002/sim.7220DPP, DPPOS20673Secondary Research
Flexible Evaluation of Surrogate Markers with Bayesian Model AveragingJournal2024DPP23555Secondary Research
Healthy Living Partnerships to Prevent Diabetes: recruitment and baseline characteristics.20974289PMC3005835Journal201110.1016/j.cct.2010.10.006DPP808Secondary Research
Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.15793191PMC1307521Journal200510.2337/diacare.28.4.888DPPContributing Study
Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program.25697494PMC4353279Journal201510.1136/bmj.h454DPP6372Secondary Research
Individualized Risk Prediction for Type 2 Diabetes: A Secondary Analysis of the Diabetes Prevention ProgramAbstract2024 https://doi.org/10.1161/circ.149.suppl_1.P131DPP23709Secondary Research
Individualized T2D risk predictionAbstract2024https://doi.org/10.2337/db24-1299-PDPP23709Secondary Research
MicroRNA Biomarkers Target Genes and Pathways Associated with Type 2 Diabetes37543292Journal202310.1016/j.diabres.2023.110868DPP21972Secondary Research
MicroRNAs Associated with Incident Diabetes in the Diabetes Prevention Program36477577Journal202210.1210/clinem/dgac714DPP21972Secondary Research
Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods.19675667PMC2720539Journal200910.1371/journal.pone.0006624DPP87Secondary Research
Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.28974480PMC5933403Journal201710.1289/EHP1612DPP20499Secondary Research
Prediabetes subgroups, T2D risk, and differential intervention effectsAbstract2024https://doi.org/10.2337/db24-1387-PDPP23709Secondary Research
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.15793255PMC1351025Journal200510.2337/diabetes.54.4.1150DPPContributing Study
Quantifying the Feasibility of Shortening Clinical Trial Duration Using Surrogate Markers34474500PMC8595715Journal202110.1002/sim.9185DPP, DPPOS22454, 23555Secondary Research
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.11832527PMC1370926Journal200210.1056/NEJMoa012512DPP, DPPOSContributing Study
Review of Databases for Human MicroRNA-mRNA Interactions37098414Journal202310.1093/database/baad014DPP21972Secondary Research
Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.27375287PMC5841614Journal201610.1093/ije/dyw118ATN, MTOPS, HEMO, FAVORIT, DPP, SISTEr, HALT-C6371, 6372, 6830, 8068, 8148, 8168, 8169, 8170Secondary Research
Robust Approach to Combining Multiple Markers to Improve Surrogacy35426444PMC10347081Journal202210.1111/biom.13677DPP, DPPOS22454, 23555Secondary Research
Robust approach to combining multiple markers to improve surrogacy35426444PMC10347081Journal202310.1111/biom.13677DPP23555Secondary Research
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.16046308PMC1360738Journal200510.2337/diabetes.54.8.2404DPPContributing Study
Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.26200237PMC4596040Journal201510.1210/jc.2015-2328DPPContributing Study
Testosterone and depressive symptoms among men in the Diabetes Prevention Program.27371769PMC5070975Journal201610.1016/j.psyneuen.2016.06.009DPPContributing Study
The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.11092283PMC1360735Journal200010.2337/diacare.23.11.1619DPPContributing Study
The Role of Racial and Ethnic Factors in MicroRNA Expression and Risk for Type 2 Diabetes35368704Journal202210.3389/fgene.2022.853633DPP21972Secondary Research
The comparative efficacy of lifestyle intervention and metformin by educational attainment in the Diabetes Prevention Program.26024851PMC4490008Journal201510.1016/j.ypmed.2015.05.017DPP5909Secondary Research
Using a Surrogate Marker for Early Testing of a Treatment EffectConference Presentation2019DPP, DPPOS23555Secondary Research
Weight Loss, Lifestyle Intervention, and Metformin Affect Longitudinal Relationship of Insulin Secretion and Sensitivity36062951PMC9923796Journal202210.1210/clinem/dgac509DPPOS, DPP21434Secondary Research
Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program.18421273Journal200810.1038/oby.2008.224DPP70Secondary Research
  • Previous
  • 1(current)
  • Next
Page